Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer

Clinical trial NCT06938724 · RECRUITING

Trial details

NCT number: NCT06938724
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm Malignant Female

Start date: 2025-07-25
Primary completion: 2035-07-25
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.